Atlas Trials

HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications

Clinical trial NCT02775227 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02775227
Sponsor
Helsinki University Central Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Pancreatic FistulaPancreatic Neoplasms
Start date
2016-05-01
Primary completion
2019-01-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.